The BL21/LRa05 intervention significantly decreased the levels of serum LPS and inflammatory factors, particularly TNFα and IL6, compared with those in the T2DM mice, the levels in which were not significantly different from those in the CTL group. The gene discussed is TNF; the disease is type 2 diabetes mellitus.